{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:02:18Z","timestamp":1787731338459,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005375","name":"Latvian Council of Science","doi-asserted-by":"publisher","award":["108\/2012"],"award-info":[{"award-number":["108\/2012"]}],"id":[{"id":"10.13039\/501100005375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbr.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T21:01:41Z","timestamp":1496437301000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["The activity of selective sigma-1 receptor ligands in seizure models in vivo"],"prefix":"10.1016","volume":"328","author":[{"given":"Edijs","family":"Vavers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiba","family":"Svalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasma","family":"Lauberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmars","family":"Stonans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilga","family":"Misane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Dambrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liga","family":"Zvejniece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2017.04.008_bib0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/mol.115.101170","article-title":"Biochemical pharmacology of the sigma-1 receptor","volume":"89","author":"Chu","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjp.0705998","article-title":"The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan","volume":"144","author":"Shin","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0024-3205(01)01181-X","article-title":"Carbetapentane attenuates kainate-induced seizures via sigma-1 receptor modulation","volume":"69","author":"Kim","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2017.04.008_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1476-5381.1990.tb14668.x","article-title":"Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047)","volume":"99","author":"Singh","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2011.02.017","article-title":"Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine","volume":"118","author":"Matsumoto","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbr.2017.04.008_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(99)00113-2","article-title":"Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity","volume":"370","author":"McCracken","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0035","unstructured":"G. Skuza, Effect of sigma ligands on the cocaine-induced convulsions in mice, Pol. J. Pharmacol. 51, 477\u2013483."},{"key":"10.1016\/j.bbr.2017.04.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)10081-3","article-title":"Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine","volume":"35","author":"Musacchio","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.phrs.2016.03.016","article-title":"The challenges of treating epilepsy with 25 antiepileptic drugs","volume":"107","author":"Santulli","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2017.04.008_bib0050","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0306-3623(96)00062-6","article-title":"Basis of the antiseizure action of phenytoin","volume":"27","author":"Tunnicliff","year":"1996","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0055","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1111\/bph.13195","article-title":"Allosteric modulation of sigma-1 receptors elicits anti-seizure activities","volume":"172","author":"Guo","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(01)02152-7","article-title":"The anti-amnesic effects of sigma1 (sigma1) receptor agonists confirmed by in vivo antisense strategy in the mouse","volume":"898","author":"Maurice","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2017.04.008_bib0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0006-8993(96)00565-3","article-title":"Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM)","volume":"733","author":"Maurice","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2017.04.008_bib0070","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","article-title":"Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity","volume":"16","author":"Marrazzo","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2017.04.008_bib0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S1734-1140(09)70181-1","article-title":"Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL\/6J mice","volume":"61","author":"Skuza","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbr.2017.04.008_bib0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1471-4159.2007.05058.x","article-title":"Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation","volume":"104","author":"Shen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2017.04.008_bib0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pain.2009.03.011","article-title":"Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice","volume":"143","author":"Entrena","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.bbr.2017.04.008_bib0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bph.12506","article-title":"The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors","volume":"171","author":"Zvejniece","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0100","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.bbr.2017.04.008_bib0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/FBP.0b013e32833d5a59","article-title":"Mildronate exerts acute anticonvulsant and antihypnotic effects","volume":"21","author":"Zvejniece","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60205-6","article-title":"Epilepsy and gamma-aminobutyric acid-mediated inhibition","volume":"17","author":"Meldrum","year":"1975","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.physbeh.2009.09.005","article-title":"A revised Racine\u2019s scale for PTZ-induced seizures in rats","volume":"98","author":"L\u00fcttjohann","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2017.04.008_bib0125","doi-asserted-by":"crossref","first-page":"PL285","DOI":"10.1016\/0024-3205(93)90588-T","article-title":"NE-100, a novel sigma receptor ligand: in vivo tests","volume":"53","author":"Okuyama","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2017.04.008_bib0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0091-3057(91)90200-L","article-title":"Naloxone enhances epileptogenic and behavioral effects of pentazocine in rats","volume":"39","author":"Dirksen","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2017.04.008_bib0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0306-3623(94)00191-O","article-title":"3-(3-Hydroxyphenyl)-N-(1-propyl)piperidine elicits convulsant effects in mice","volume":"26","author":"Pieretti","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1126\/science.504986","article-title":"Classification of opioids on the basis of change in seizure threshold in rats","volume":"206","author":"Cowan","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.bbr.2017.04.008_bib0145","first-page":"1","article-title":"Opioid receptor mediated anticonvulsant effect of pentazocine","volume":"52","author":"Khanna","year":"1998","journal-title":"Indian J. Med. Sci."},{"key":"10.1016\/j.bbr.2017.04.008_bib0150","series-title":"Sigma Receptors: Chemistry, Cell Biology and Clinical Implications","author":"Matsumoto","year":"2007"},{"key":"10.1016\/j.bbr.2017.04.008_bib0155","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0024-3205(02)02505-5","article-title":"New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice","volume":"72","author":"Kim","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2017.04.008_bib0160","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1038\/srep24591","article-title":"The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats","volume":"6","author":"Gris","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2017.04.008_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-10-11","article-title":"Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice","volume":"10","author":"Nieto","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bbr.2017.04.008_bib0170","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization","volume":"166","author":"Romero","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2125.2012.04333.x","article-title":"Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies","volume":"75","author":"Abadias","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0180","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-3565(25)20283-X","article-title":"Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand","volume":"259","author":"Su","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2017.04.008_bib0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0014-2999(93)90607-J","article-title":"The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex","volume":"236","author":"Roth","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0190","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.bmc.2013.03.016","article-title":"Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor","volume":"21","author":"Veinberg","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbr.2017.04.008_bib0195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/mol.112.083840","article-title":"SKF83959 is a potent allosteric modulator of sigma-1 receptor","volume":"83","author":"Guo","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbr.2017.04.008_bib0200","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11011-015-9650-8","article-title":"Comparative behavioral and neurochemical analysis of phenytoin and valproate treatment on epilepsy induced learning and memory deficit: search for add on therapy","volume":"30","author":"Mishra","year":"2015","journal-title":"Metab. Brain Dis."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817301614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432817301614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:16:34Z","timestamp":1750288594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432817301614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":40,"alternative-id":["S0166432817301614"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2017.04.008","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The activity of selective sigma-1 receptor ligands in seizure models in vivo","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}